Neal Jain, MD | |
4915 E Baseline Rd, Suite 112, Gilbert, AZ 85234-2966 | |
(480) 626-6600 | |
(480) 626-6604 |
Full Name | Neal Jain |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 4915 E Baseline Rd, Gilbert, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356390512 | NPI | - | NPPES |
60229 | Other | WI | DEAN HEALTH INSURANCE |
34556400 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 46685-020 (Wisconsin) | Secondary |
207K00000X | Allergy & Immunology | 42305 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Neal Jain, MD 4915 E Baseline Rd, Suite 112, Gilbert, AZ 85234-2965 Ph: (480) 626-6600 | Neal Jain, MD 4915 E Baseline Rd, Suite 112, Gilbert, AZ 85234-2966 Ph: (480) 626-6600 |
News Archive
Scientists at the University of California, San Diego and the Massachusetts Institute of Technology have described a new method for detecting liver cancer metastases in mice. The approach uses over-the-counter probiotics genetically programmed to produce signals easily detectable in urine when liver cancer metastases are present.
Sonova Holding AG, the world's leading provider of hearing systems, announced today that it has entered into a share purchase agreement with the shareholders of Advanced Bionics Corporation, Los Angeles, USA.
Physical manifestations of negative memories in the hippocampus could underlie cognitive symptoms of depression, according to research in mice published in JNeurosci. Inhibiting these manifestations could be a future treatment route.
Relypsa, Inc. today announced the start of dosing in a Phase 2b clinical trial of RLY5016 for the treatment of hyperkalemia in patients with diabetic nephropathy and chronic kidney disease (CKD). RLY5016 is a high capacity, non-absorbed, polymer-based potassium binder that is orally administered and has been shown to control serum potassium levels in previous studies.
The Centre for Addiction and Mental Health and Impel NeuroPharma have signed a licensing agreement to advance a new neuropeptide-based therapeutic approach shown to be effective in treating depression.
› Verified 3 days ago
Dr. Sam Reed Shimamoto, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4915 E Baseline Rd, Suite 112, Gilbert, AZ 85234 Phone: 480-626-6600 Fax: 480-626-6604 | |
Dr. Earl Alan Labovitz, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2915 E Baseline Rd, Suite 121, Gilbert, AZ 85234 Phone: 480-507-1997 Fax: 480-507-3638 | |
Dr. Deepa Maria Grandon, M.D Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 4915 E Baseline Rd, Suite 112, Gilbert, AZ 85234 Phone: 480-626-6600 Fax: 480-626-6604 |